A. Esquirol

发表

Foetal-neonatal alloimmune thrombocytopenia due to anti-HPA-2b antibodies present in the serum of a mother initially mistyped as HPA-1a negative.

E. Farssac, E. Muñiz‐Díaz, A. Esquirol, 2012, Blood transfusion = Trasfusione del sangue.

Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting

P. Ljungman, M. Remberger, O. Ringdén, 2018, Medical Oncology.

Outcomes of Advanced Hodgkin Lymphoma after Umbilical Cord Blood Transplantation: A Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party Study.

S. Montoto, P. Chevallier, D. Blaise, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party

S. Montoto, I. Yakoub-Agha, D. Blaise, 2018, Cancer.

FcγRIIb expression in early stage chronic lymphocytic leukemia

E. Montserrat, J. Delgado, J. Sierra, 2017, Leukemia & lymphoma.

Plerixafor in patients with lymphoma and multiple myeloma: effectiveness in cases with very low circulating CD34+ cell levels and preemptive intervention vs remobilization

J. Sancho, J. Sierra, J. Martí, 2015, Bone Marrow Transplantation.

Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working Party

S. Montoto, N. Kröger, P. Dreger, 2019, Bone Marrow Transplantation.

Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time

F. Fernández‐Avilés, R. Martino, R. Duarte, 2015, Bone Marrow Transplantation.

Brentuximab Vedotin for relapsed Hodgkin lymphoma after allogeneic hematopoietic cell transplantation: a report from the EBMT Lymphoma Working Party

S. Montoto, I. Yakoub-Agha, D. Blaise, 2020 .

Allogeneic Stem Cell Transplantation in Mature T Cell and Natural Killer/T Neoplasias: A Registry Study from Spanish GETH/GELTAMO Centers.

E. González-Barca, C. Solano, R. Martino, 2021, Transplantation and cellular therapy.

Effect of Sirolimus Exposure on the Need for Preemptive Antiviral Therapy for Cytomeglovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.

J. Sierra, C. Solano, E. Giménez, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation

J. Perkins, C. Solano, J. Pidala, 2017, Bone Marrow Transplantation.

Outcome of Haploidentical SCT in Patients with Acute Leukemia

J. Sierra, A. Esquirol, 2017 .

Defibrotide in hematopoietic stem cell transplantation: A multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH)

J. M. Fernández, M. Díaz, I. Badell, 2021, European journal of haematology.

Bone Marrow WT1 Levels in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplasia: Clinically Relevant Time Points and 100 Copies Threshold Value.

J. Sierra, S. Brunet, J. Nomdedéu, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chronic Lymphocytic Leukemia: Clinical Stages Maintain Their Prognostic Significance Over the Course of the Disease and Are Surrogates for Response to Therapy

J. Briones, J. Sierra, S. Brunet, 2018, Clinical lymphoma, myeloma & leukemia.

Allogeneic stem cell transplantation in HIV-1 infected patients with high-risk hematological disorders.

J. Anguita, J. Sanz, J. Díez-Martín, 2019, AIDS.

Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis

F. Bosch, C. Solano, R. Martino, 2020, Leukemia & lymphoma.

GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: results of a multicenter study

C. Solano, F. Sánchez-Guijo, J. Pérez-Simón, 2016, Bone Marrow Transplantation.

Incorporating posttransplant cyclophosphamide-based prophylaxis as standard-of-care outside the haploidentical setting: challenges and review of the literature

J. Briones, J. Sierra, S. Brunet, 2019, Bone Marrow Transplantation.

A Time-to-Event Model for Acute Kidney Injury after Reduced-Intensity Conditioning Stem Cell Transplantation Using a Tacrolimus- and Sirolimus-based Graft-versus-Host Disease Prophylaxis.

J. Queraltó, M. Terol, J. Sierra, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Low Rate of Invasive Fungal Infections During Induction and Consolidation Chemotherapy for Adults with De Novo Acute Myeloid Leukemia Without Anti-mold Prophylaxis: Single-Center 2002–2018 Empirical/Pre-emptive Approach

J. Briones, J. Sierra, S. Brunet, 2020, Mycopathologia.

Severe infections after single umbilical cord blood transplantation in adults with or without the co‐infusion of CD34+ cells from a third‐party donor: results of a multicenter study from the Grupo Español de Trasplante Hematopoyético (GETH)

R. Martino, R. Duarte, J. García-Marco, 2015, Transplant infectious disease : an official journal of the Transplantation Society.

Cytomegalovirus DNAemia and risk of mortality in allogeneic hematopoietic stem cell transplantation: Analysis from the Spanish Hematopoietic Transplantation and Cell Therapy Group

E. Albert, C. Solano, E. Giménez, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Bone marrow WT1 levels in patients with myeloid neoplasms treated with 5‐azacytidine: Identification of responding patients

J. Sierra, S. Brunet, J. Nomdedéu, 2019, European journal of haematology.

CD34+ Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome .

J. Sierra, M. Perales, S. Devlin, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CD34+ selection vs. reduced-intensity conditioning and unmodified graft for allogeneic hematopoietic cell transplantation in patients with AML and MDS > 50 years

J. Sierra, M. Perales, S. Devlin, 2019 .

Combining Three Different Pretransplantation Scores Improves Predictive Value in Patients after Haploidentical Stem Cell Transplantation with Thiotepa, Busulfan, and Fludarabine Conditioning and Post-Transplantation Cyclophosphamide

R. Martino, A. Torío, C. Ferrá, 2021, Transplantation and Cellular Therapy.

Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide

J. Sierra, R. Martino, C. Ferrá, 2021, Bone Marrow Transplantation.

Umbilical cord blood transplantation in adults with advanced hodgkin's disease: high incidence of post‐transplant lymphoproliferative disease

M. Terol, J. Sierra, C. Solano, 2016, European journal of haematology.

Usefulness of thrombopoietin receptor agonists for persistent clinically relevant thrombocytopenia after allogeneic stem cell transplantation

J. Sierra, R. Martino, S. Novelli, 2018, European journal of haematology.

When an HLA identical donor is not available in adults with hematological neoplasms: single-center comparison of single-unit cord blood transplantation and haploidentical-related PBSC transplantation with PTCy using a standardized conditioning platform (thiotepa-busulfan-fludarabine)

J. Briones, J. Sierra, S. Brunet, 2019, Annals of Hematology.

Post thawing viable CD34+ Cells dose is a better predictor of clinical outcome in lymphoma patients undergoing autologous stem cell transplantation

O. Valero, M. Lozano, J. Cid, 2022, Bone Marrow Transplantation.

Single-agent GvHD prophylaxis with tacrolimus after post-transplant high-dose cyclophosphamide is a valid option for haploidentical transplantation in adults with hematological malignancies

S. Brunet, R. Martino, C. Ferrá, 2017, Bone Marrow Transplantation.

Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease

J. Briones, S. Brunet, R. Martino, 2017, Bone Marrow Transplantation.

Transplant results in adults with Fanconi anaemia

R. Porcher, N. Kröger, M. Aljurf, 2018, British journal of haematology.

Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation

R. Martino, A. Esquirol, I. García-Cadenas, 2021, Bone Marrow Transplantation.

Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor

S. Montoto, N. Russell, E. Jantunen, 2019, Bone Marrow Transplantation.

Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab

J. Briones, S. Brunet, R. Martino, 2015, Bone Marrow Transplantation.

Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma.

M. Terol, C. Solano, P. Armand, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of transplant eligibility and availability of a human leukocyte antigen-identical matched related donor on outcome of older patients with acute lymphoblastic leukemia

J. Hernández-Rivas, R. Martino, J. Ribera, 2015, Leukemia & lymphoma.

Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment

E. Albert, C. Solano, E. Giménez, 2020, Bone Marrow Transplantation.

Efficacy and safety of Ruxolitinib in steroid-refractory/dependent chronic graft-versus-host disease: Real-world Data and Challenges.

J. Briones, J. Sierra, R. Martino, 2021, Transplantation and cellular therapy.

Assessment of the association between cytomegalovirus DNAemia and subsequent acute graft‐versus‐host disease in allogeneic peripheral blood stem cell transplantation: A multicenter study from the Spanish hematopoietic transplantation and cell therapy group

E. Albert, C. Solano, E. Giménez, 2021, Transplant infectious disease : an official journal of the Transplantation Society.

Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies

J. Bourhis, N. Ifrah, E. Gluckman, 2017, British journal of haematology.

Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

S. Montoto, E. González-Barca, D. Blaise, 2019, Bone Marrow Transplantation.

Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party

N. Kröger, I. Yakoub-Agha, E. Tholouli, 2016, Bone Marrow Transplantation.

Addition of plerixafor to G-CSF in poor mobilizing healthy related donors overcame mobilization failure: An observational case series on behalf of the Grupo Español de Trasplante Hematopoyético (GETH).

M. Lozano, J. Cid, C. Martínez, 2021, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Impact of Cyclosporine Levels on the Development of Acute Graft versus Host Disease after Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation

J. Briones, J. Sierra, S. Brunet, 2014, Mediators of inflammation.

Allogeneic hematopoietic stem cell transplantation for non-Hodgkin’s lymphomas: a retrospective analysis of 77 cases

J. Briones, J. Sierra, R. Martino, 2017, Annals of Hematology.

Do Patients and Physicians Agree When They Assess Quality of Life?

J. Briones, A. Barata, S. Brunet, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pharmacogenetic analysis in the treatment of Hodgkin lymphoma

M. Baiget, D. Páez, L. Paré, 2013, Leukemia & lymphoma.

Updated experience with inolimomab as treatment for corticosteroid-refractory acute graft-versus-host disease.

J. Briones, J. Sierra, S. Brunet, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Successful Outcome in Patients with Myelofibrosis Undergoing Allogeneic Donor Hematopoietic Cell Transplantation Using Reduced-Doses of Post-Transplant Cyclophosphamide: challenges and review of the literature.

J. Briones, R. Martino, S. Miqueleiz, 2023, Transplantation and cellular therapy.

Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe

P. Chevallier, J. Sanz, J. Cornelissen, 2022, Blood advances.

Validation of a new integrated prognostic score to predict non-relapse mortality in patients undergoing reduced-intensity conditioning allogeneic hematopoietic cell transplantation

R. Martino, S. Pérez-Hoyos, A. Esquirol, 2015, Bone Marrow Transplantation.

Sequence matters: Total body irradiation (TBI)‐based myeloablative conditioning with post‐transplant cyclophosphamide may reduce the early nonrelapse mortality compared with pretransplant cyclophosphamide plus TBI

J. Briones, R. Martino, S. Miqueleiz, 2023, European journal of haematology.

mRNA-1273 SARS-CoV-2 vaccine in recently transplanted allogeneic hematopoietic cell transplant recipients: dynamics of cellular and humoral immune responses and booster effect

R. Martino, S. Vidal, E. Moga, 2023, Leukemia research.

Age, CD34+ cell dose, conditioning and pre‐transplant cytopenias can help predict transfusion support in lymphoma patients undergoing autologous stem cell transplantation

J. Briones, R. Martino, S. Novelli, 2023, Vox sanguinis.